Investing in Modern and Advanced Treatment Devices to Help Treatment-Resistant Patient Populations
In the media » Investing in Modern and Advanced Treatment Devices to Help Treatment-Resistant Patient Populations
BrainsWay Chief Medical Officer, Dr. Aron Tendler, describes to HIT Consultant the landscape of modern treatment options for patients that do not sufficiently benefit from medication and therapy.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy